S100a1 gene therapy in small and large animals

Methods in Molecular Biology

Volumn 963, Issue , 2013, Pages 407-420

  Most, Patrick ^a   Raake, Philip ^a   Weber, Christophe ^a   Katus, Hugo A ^a   Pleger, Sven T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adeno associated virus; Adenovirus; Antegrade delivery; Calcium; Cardioselective; EF hand; Efficacy; Myocardial gene therapy; Retroinfusion; S100A1

Indexed keywords

PROTEIN; PROTEIN S100A1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; PROTEIN S 100; S100A1 PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL MODEL; BODY TEMPERATURE; CARDIAC MUSCLE; FREEZING; HEART FAILURE; HEART FUNCTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROTEIN EXPRESSION; RAT; SUPERIOR CAVA VEIN; ANIMAL; ARTICLE; GENE THERAPY; GENE TRANSFER; GENETICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METABOLISM; METHODOLOGY; SWINE;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEART FAILURE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; S100 PROTEINS; SWINE;

EID: 84878753597     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-230-8_25     Document Type: Chapter

References (30)

1. del Monte F, Hajjar R (2003) Targeting calium cycling proteins in heart failure through gene transfer. J Physiol 546:49–61.
2. Wehrens XH, Marks AR (2004) Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov 3:565–573.
3. Wasala NB, Shin JH, Duan D (2011) The evolution of heart gene delivery vectors. J Gene Med 13:557–565.
4. Raake PW, Tscheschner H, Reinkober J, RitterhoffJ, Katus HA, Koch WJ, Most P (2011) Gene therapy targets in heart failure: the path to translation. Clin Pharmacol Ther 90:542–553.
5. Heine HL, Leong HS, Rossi FM, McManus BM, Podor TJ (2005) Strategies of conditional gene expression in myocardium: an overview. Methods Mol Med 112:109–154.
6. Ishikawa K, Tilemann L, Fish K, Hajjar RJ (2011) Gene delivery methods in cardiac gene therapy. J Gene Med 13:566–572.
7. Dixon JA, Spinale FG (2009) Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2:262–271.
8. Pleger ST, Boucher M, Most P, Koch WJ (2007) Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy. J Card Fail 13:401–414.
9. Raake PW, Hinkel R, Müller S, Delker S, Kreuzpointner R, Kupatt C, Katus HA, Kleinschmidt JA, Boekstegers P, Müller OJ (2008) Cardio-speci fic long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 15:12–17.
10. Emani SM, Shah AS, Bowman MK, Emani S, Wilson K, Glower DD, Koch WJ (2003) Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 8:306–313.
11. Wang J, Faust SM, Rabinowitz JE (2011) The next step in gene delivery: molecular engineering of adeno-associated virus serotypes. J Mol Cell Cardiol 50:793–802.
12. Raake P, von Degenfeld G, Hinkel R, Vachenauer R, Sandner T, Beller S, Andrees M, Kupatt C, Schuler G, Boekstegers P (2004) Myocardial gene transfer by selective pressureregulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 44:1124–1129.
13. Pleger ST, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R, Schinkel S, Leuchs B, Ludwig J, Qiu G, Weber C, Raake P, Koch WJ, Katus HA, Müller OJ, Most P (2011) Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 20:92ra64.
14. Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, Gao E, Dasgupta A, Rengo G, Remppis A, Katus HA, Eckhart AD, Rabinowitz JE, Koch WJ (2007) Stable myocardial-speci fic AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 115:2506–2515.
15. Kraus C, Rohde D, Weidenhammer C, Qiu G, Pleger ST, Voelkers M, Boerries M, Remppis A, Katus HA, Most P (2009) S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol 47:445–455.
16. Boerries M, Most P, Gledhill JR, Walker JE, Katus HA, Koch WJ, Aebi U, Schoenenberger CA (2007) Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol Cell Biol 27:4365–4373.
17. Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Börries M, Niroomand F, Pieske B, Janssen PM, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Katus HA, Remppis A (2001) S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci USA 98:13889–13894.
18. Most P, Remppis A, Pleger ST, Löf fler E, Ehlermann P, Bernotat J, Kleuss C, Heierhorst J, Ruiz P, Witt H, Karczewski P, Mao L, Rockman HA, Duncan SJ, Katus HA, Koch WJ (2003) Transgenic overexpression of the Ca2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278:33809–33817.
19. Most P, Seifert H, Gao E, Funakoshi H, Völkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR Jr, Eckhart AD, Feldman AM, Koch WJ (2006) Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114:1258–1268.
20. Tsoporis JN, Marks A, Zimmer DB, McMahon C, Parker TG (2003) The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart. Mol Cell Biochem 242:27–33.
21. Völkers M, Loughrey CM, Macquaide N, Remppis A, DeGeorge BR Jr, Wegner FV, Friedrich O, Fink RH, Koch WJ, Smith GL, Most P (2007) S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium 41:135–143.
22. Most P, Pleger ST, Völkers M, Heidt B, Boerries M, Weichenhan D, Löf fler E, Janssen PM, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ (2004) Cardiac adenoviral S100A1 gene transfer rescues failing myocardium. J Clin Invest 114:1550–1563.
23. Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P (2005) S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12:1120–1129.
24. Rohde D, RitterhoffJ, Voelkers M, Katus HA, Parker TG, Most P (2010) S100A1: a multifaceted therapeutic target in cardiovascular disease. J Cardiovasc Transl Res 3:525–537, Review.
25. Völkers M, Rohde D, Goodman C, Most P (2010) S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function. J Biomed Biotechnol 2010:178614.
26. Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Lerchenmüller C, Mather PJ, Eckhart AD, Katus HA, Carrel T, Koch WJ, Most P (2011) S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol 58:966–973.
27. Maurice JP, Hata JA, Shah AS, White DC, McDonald PH, Dolber PC, Wilson KH, Lefkowitz RJ, Glower DD, Koch WJ (1999) Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest 104:21–29.
28. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ, Rosenzweig A (1998) Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 95:5251–5256.
29. Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J Jr, Chien KR (2002) Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8:864–871.
30. Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C, Steinbeck G, Baretton G, Middeler G, Katus HA, Franz WM (2000) Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 7:232–240.